PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsBRCA1 cancer study suggests alternative to major surgery

BioNews

BRCA1 cancer study suggests alternative to major surgery

Published 28 March 2014 posted in News and appears in BioNews 748

Author

Dr Sarah West

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

BRCA1 mutations put carriers at high risk of cancer by failing to protect cells against the effects of high levels of oestrogen hormone found in breast and ovary tissue, researchers have established...

BRCA1 mutations put carriers at high risk of cancer by failing to protect cells
against the effects of high levels of oestrogen hormone found in breast and ovary tissue, researchers
have established.

A link between oestrogen and BRCA1 had long been suspected, but the study confirms it
and demonstrates the underlying mechanism.

The information could allow the development of preventative treatment strategies
using already available drugs as an alternative to the major surgery many women
choose to have to reduce their cancer risk.

One in 1,000 women in the UK have BRCA1
mutations that carry with them up to an 85 percent increased risk of breast cancer and
up to a 45 percent increased risk of ovarian cancer. BRCA1 mutations are
mostly inherited.

Currently, the only way to reduce the
increased cancer risk from a BRCA1 mutation is major surgery in the form
of double mastectomy (removal of both breasts) and oophorectomy (removal of
ovaries).

BRCA1 is a tumour suppressor gene and
normally works to maintain genome stability. As BRCA1 performs this function in
all cells, the researchers were interested in why mutations mainly led to
tumour formation in tissues regulated by oestrogen.

In cell culture experiments, the researchers showed
a clear link between high levels of hormones and DNA damage, which can cause cancer. They reported that oestrogen and its metabolites can cause double-strand
breaks
in DNA in certain breast cells.

They also showed that BRCA1 is required to
repair these DNA breaks and also to regulate the expression of oestrogen-metabolising
enzymes in breast tissue, thus preventing DNA damage from oestrogen
metabolites.

Finally, the scientists looked at human cell
lines carrying BRCA1 mutations. They concluded that BRCA1-mutated cells in oestrogen-regulated
tissue, such as the breast and ovary, cannot counteract high levels of hormones
and their metabolites, and this leads to DNA damage and tumour formation.

'It's the first really credible evidence that
oestrogen is driving cancer in women with a BRCA1 gene mutation', said study
leader Dr Kienan Savage from Queen's University Belfast. 'Because of this
discovery, we now have the opportunity to propose an alternative treatment to
surgery. It also opens up the possibility of pausing treatment for a period for
women to have children, if desired'.

Drugs already exist that can reduce oestrogen
levels. The researchers now hope to secure funding to
test them as possible preventative treatments in clinical trials later in the
year.

The research, which took four years to
complete, was funded by Cancer Focus Northern Ireland and Cancer Research UK. Cancer
Focus Northern Ireland chief executive Roisin Foster said the research 'has the
potential in the foreseeable future to benefit women all over the world'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 September 2014 • 2 minutes read

Canadian cancer centre reports 'Angelina effect'

by Dr Kimberley Bryon-Dodd

Angelina Jolie's decision to openly discuss her preventative double mastectomy after testing positive for a dangerous BRCA1 mutation may have led to a dramatic upswing in referrals to genetic counselling services, if results from a Canadian study are widely applicable...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
7 April 2014 • 4 minutes read

Relative Risk: Breast Cancer and Genetics

by Matthew Thomas

At the launch of their 'Breast Cancer: Chances, Choices and Genetics' project, a panel of experts and a lively audience grappled with the difficult topic of cancer genetics...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
7 April 2014 • 4 minutes read

Unlocking the genetics of breast cancer

by Baroness Delyth Morgan

The news of Angelina Jolie's mastectomy last year brought breast cancer genetics, risk and prevention into the international spotlight. Her decision was only possible due to the efforts of researchers, over the past twenty years and more, to identify the inherited genetic mutations...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 February 2014 • 2 minutes read

Women with BRCA mutation 'should have ovaries removed by age 35'

by Dr Lucy Freem

Ovary removal to prevent cancer in those with BRCA1 mutations should be carried out by 35, according to research on cancer survival...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2013 • 2 minutes read

Breast cancer risk may still be higher despite BRCA-negative test results

by Dr Charlotte Warren-Gash

Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 October 2013 • 2 minutes read

The Jolie effect: breast cancer gene testing increases, but so do surgery requests

by Ruth Retassie

A London clinic has reported an increase in the number of requests for BRCA genetic testing and preventative mastectomies since Angelina Jolie's announcement last May that she had undergone a double mastectomy....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 May 2013 • 4 minutes read

Difficult decisions faced by women with a BRCA gene mutation

by Chris Jacobs

The news about Angelina Jolie opting for a double mastectomy to reduce her risk of breast cancer has undoubtedly raised concerns among women with a family history of the disease. Whilst this news has certainly raised awareness of hereditary cancer, there are two key points that it is important to emphasize...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Epigenetic blood test for children 'predicts' obesity five years later

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

6 July 2022 • 1 minute read

Frozen embryo transfers linked to high blood pressure in pregnancy

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856